These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study. Farrell GC; Bacon BR; Goldin RD Hepatology; 1998 Apr; 27(4):1121-7. PubMed ID: 9537453 [TBL] [Abstract][Full Text] [Related]
5. Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: a multicenter, controlled, randomized trial. Le Groupe D'étude et De Traitement du Virus De L'hépatite C (Get.Vhc). Payen JL; Izopet J; Galindo-Migeot V; Lauwers-Cances V; Zarski JP; Seigneurin JM; Dussaix E; Voigt JJ; Selves J; Barange K; Puel J; Pascal JP Hepatology; 1998 Dec; 28(6):1680-6. PubMed ID: 9828235 [TBL] [Abstract][Full Text] [Related]
6. [Treatment with interferon alfa-2b in patients with chronic hepatitis caused by hepatitis C virus: predictive factors for the response, relapse and early development to cirrhosis after treatment]. Pérez Roldán F; De Diego A; Casado M; Matilla A; Bañares R; García-Durán F; Salcedo M; Cos E; Clemente G Rev Esp Enferm Dig; 1996 Sep; 88(9):609-15. PubMed ID: 8962775 [TBL] [Abstract][Full Text] [Related]
8. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience. Schvarcz R; Ando Y; Sönnerborg A; Weiland O J Hepatol; 1995; 23 Suppl 2():17-21. PubMed ID: 8720289 [TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration. Poynard T; Leroy V; Cohard M; Thevenot T; Mathurin P; Opolon P; Zarski JP Hepatology; 1996 Oct; 24(4):778-89. PubMed ID: 8855176 [TBL] [Abstract][Full Text] [Related]
10. Therapy of hepatitis C: re-treatment with alpha interferon. Alberti A; Chemello L; Noventa F; Cavalletto L; De Salvo G Hepatology; 1997 Sep; 26(3 Suppl 1):137S-142S. PubMed ID: 9305679 [TBL] [Abstract][Full Text] [Related]
11. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. Davis GL; Esteban-Mur R; Rustgi V; Hoefs J; Gordon SC; Trepo C; Shiffman ML; Zeuzem S; Craxi A; Ling MH; Albrecht J N Engl J Med; 1998 Nov; 339(21):1493-9. PubMed ID: 9819447 [TBL] [Abstract][Full Text] [Related]
13. Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: a randomized multicenter trial. Hepatitis Interventional Therapy Group. Lindsay KL; Davis GL; Schiff ER; Bodenheimer HC; Balart LA; Dienstag JL; Perrillo RP; Tamburro CH; Goff JS; Everson GT; Silva M; Katkov WN; Goodman Z; Lau JY; Maertens G; Gogate J; Sanghvi B; Albrecht J Hepatology; 1996 Nov; 24(5):1034-40. PubMed ID: 8903371 [TBL] [Abstract][Full Text] [Related]
14. Combination antiviral therapy with ribavirin and interferon alfa in interferon alfa relapsers and non-responders: Italian experience. Brillanti S; Miglioli M; Barbara L J Hepatol; 1995; 23 Suppl 2():13-5; discussion 15-6. PubMed ID: 8720288 [TBL] [Abstract][Full Text] [Related]
15. Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin. Ahmad J; Dodson SF; Demetris AJ; Fung JJ; Shakil AO Liver Transpl; 2001 Oct; 7(10):863-9. PubMed ID: 11679984 [TBL] [Abstract][Full Text] [Related]
16. Biochemical and virological outcome of patients with chronic hepatitis C treated with interferon alfa-2b for 6 or 12 months: a 4-year follow-up of 211 patients. Manesis EK; Papaioannou C; Gioustozi A; Kafiri G; Koskinas J; Hadziyannis SJ Hepatology; 1997 Sep; 26(3):734-9. PubMed ID: 9303505 [TBL] [Abstract][Full Text] [Related]
17. Biochemical and virological response of chronic hepatitis C after treatment with interferon-alpha for 6 or 12 months: predictors of sustained remission. Papatheodoridis GV; Katsoulidou A; Touloumi G; Delladetsima JK; Hatzakis A; Tassopoulos NC Eur J Gastroenterol Hepatol; 1996 May; 8(5):469-75. PubMed ID: 8804876 [TBL] [Abstract][Full Text] [Related]
18. Therapy of hepatitis C: alpha interferon and ribavirin. Reichard O; Schvarcz R; Weiland O Hepatology; 1997 Sep; 26(3 Suppl 1):108S-111S. PubMed ID: 9305674 [TBL] [Abstract][Full Text] [Related]